张迪瑞,何路平,于波

• 1:哈尔滨医科大学附属第二医院心内科心肌缺血教育部重点实验室

摘要(Abstract)：

冠状动脉易损斑块与心血管疾病的发生发展密切相关。腔内影像学技术的发展与应用极大地丰富了人们对易损斑块的认识,利用腔内影像学工具对易损斑块进行准确识别有助于早期诊断和精准治疗高危患者。血管内超声、光学相干断层成像以及近红外光谱成像是目前应用最为广泛的腔内影像学技术,其对冠状动脉易损斑块的识别和治疗既有各自特点又紧密互通。本文将基于最新的研究结果和临床实践对该领域的进展进行系统阐述。

关键词(KeyWords)： 腔内影像;动脉粥样硬化;易损斑块;斑块破裂;斑块侵蚀

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目（2016YFC1301103）

作者(Author): 张迪瑞,何路平,于波

参考文献(References)：

• [1]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要.中国循环杂志，2021,36(6):521-545.
• [2]Khan MH,Rochlani Y,Yandrapalli S,et al.Vulnerable plaque:a review of current concepts in pathophysiology and imaging.Cardiol Rev,2020,28(1):3-9.
• [3]Muller JE,Tofl er GH,Stone PH.Circadian variation and triggers of onset of acute cardiovascular disease.Circulation,1989,79(4):733-743.
• [4]Casscells W,Naghavi M,Willerson JT.Vulnerable atherosclerotic plaque:a multifocal disease.Circulation,2003,107(16):2072-2075.
• [5]Mushenkova NV,Summerhill VI,Zhang D,et al.Current advances in the diagnostic imaging of atherosclerosis:insights into the pathophysiology of vulnerable plaque.Int J Mol Sci,2020,21(8):2992.
• [6]Hafiane A.Vulnerable plaque,characteristics,detection,and potential therapies.J Cardiovasc Dev Dis,2019,6(3):26.
• [7]Stone GW,Maehara A,Lansky AJ,et al.A prospective natural-history study of coronary atherosclerosis.N Engl J Med,2011,364(3):226-235.
• [8]Raber L,Taniwaki M,Zaugg S,et al.Eff ect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries(IBIS-4):a serial intravascular ultrasonography study.Eur Heart J,2015,36(8):490-500.
• [9]Kubo T,Ino Y,Mintz GS,et al.Optical coherence tomography detection of vulnerable plaques at high risk of developing acute coronary syndrome.Eur Heart J Cardiovasc Imaging,2021,jeab028.
• [10]Xing L,Higuma T,Wang Z,et al.Clinical significance of lipid-rich plaque detected by optical coherence tomography:a 4-year followup study.J Am Coll Cardiol,2017,69(20):2502-2513.
• [11]Araki M,Yonetsu T,Kurihara O,et al.Predictors of rapid plaque progression:an optical coherence tomography study.JACCCardiovascular imaging,2021,14(8):1628-1638.
• [12]Prati F,Romagnoli E,Gatto L,et al.Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome:the CLIMA study.Eur Heart J,2020,41(3):383-391.
• [13]Cao M,Zhao L,Ren X,et al.Pancoronary plaque characteristics in stemi caused by culprit plaque erosion versus rupture:3-vessel oct study.JACC Cardiovasc Imaging,2021,14(6):1235-1245.
• [14]R?ber L,Mintz GS,Koskinas KC,et al.Clinical use of intracoronary imaging.Part 1:Guidance and optimization of coronary interventions.An expert consensus document of the european association of percutaneous cardiovascular interventions.Eur Heart J,2018,39(35):3281-3300.
• [15]Kataoka Y,Puri R,Andrews J,et al.In vivo visualization of lipid coronary atheroma with intravascular near-infrared spectroscopy.Expert Rev Cardiovasc Ther,2017,15(10):775-785.
• [16]Schuurman AS,Vroegindewey M,Kardys I,et al.Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up.Eur Heart J,2018,39(4):295-302.
• [17]Kini AS,Baber U,Kovacic JC,et al.Changes in plaque lipid content after short-term intensive versus standard statin therapy:the YELLOW trial (reduction in yellow plaque by aggressive lipidlowering therapy).J Am Coll Cardiol,2013,62(1):21-29.
• [18]Dohi T,Maehara A,Moreno PR,et al.The relationship among extent of lipid-rich plaque,lesion characteristics,and plaque progression/regression in patients with coronary artery disease:a serial near-infrared spectroscopy and intravascular ultrasound study.Eur Heart J Cardiovasc Imaging,2015,16(1):81-87.
• [19]Kuku KO,Singh M,Ozaki Y,et al.Near-infrared spectroscopy intravascular ultrasound imaging:state of the art.front cardiovasc Med,2020,7:107.
• [20]Waksman R,Di Mario C,Torguson R,et al.Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging:a prospective,cohort study.Lancet,2019,394(10209):1629-1637.
• [21]Erlinge D,Maehara A,Ben-Yehuda O,et al.Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECTⅡ）：a prospective natural history study.Lancet,2021,397(10278):985-995.
• [22]Stone GW,Maehara A,Ali ZA,et al.Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque.J Am Coll Cardiol,2020,76(20):2289-2301.
• [23]Partida RA,Libby P,Crea F,et al.Plaque erosion:A new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes.Eur Heart J,2018,39(22):2070-2076.
• [24]Jia H,Abtahian F,Aguirre AD,et al.In vivo diagnosis of plaque erosion and calcif ied nodule in patients with acute coronary syndrome by intravascular optical coherence tomography.J Am Coll Cardiol,2013,62(19):1748-1758.
• [25]Dai J,Xing L,Jia H,et al.In vivo predictors of plaque erosion in patients with st-segment elevation myocardial infarction:a clinical,angiographical,and intravascular optical coherence tomography study.Eur Heart J,2018,39(22):2077-2085.
• [26]Dai J,Fang C,Zhang S,et al.Not all plaque erosions are equal:Novel insights f rom 1,660 patients with stemi:A clinical,angiographic,and intravascular oct study.JACC Cardiovasc Imaging,2020,13(2 Pt 1):516-518.
• [27]Jia H,Dai J,Hou J,et al.Effective anti-thrombotic therapy without stenting:Intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).Eur Heart J,2017,38(11):792-800.